Stockscreener 앱 받기
1.13
27.54%
0.244
시간 외 거래:
1.13
전일 마감가:
$0.886
열려 있는:
$0.918
하루 거래량:
300.64K
Relative Volume:
1.20
시가총액:
$5.75M
수익:
-
순이익/손실:
$-21.13M
주가수익비율:
-0.2359
EPS:
-4.79
순현금흐름:
$-16.95M
1주 성능:
+29.89%
1개월 성능:
+18.90%
6개월 성능:
+79.08%
1년 성능:
+641.96%
1일 변동 폭
$0.886
$1.13
1주일 범위
$0.835
$1.13
52주 변동 폭
$0.09
$4.49
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
명칭
Matinas Biopharma Holdings Inc
전화
908-443-1860
주소
1545 Route 206 South, Suite 302, Bedminster, NJ
MTNB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
1.13 | 4.58M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-05-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | 재개 | Piper Sandler | Overweight |
| 2020-01-27 | 개시 | Piper Sandler | Overweight |
| 2020-01-24 | 개시 | SunTrust | Buy |
| 2020-01-23 | 개시 | SunTrust | Buy |
| 2020-01-09 | 개시 | Aegis Capital | Buy |
| 2019-06-26 | 개시 | H.C. Wainwright | Buy |
모두보기
Matinas Biopharma Holdings Inc 주식(MTNB)의 최신 뉴스
Can volume confirm reversal in Matinas BioPharma Holdings Inc.Free Weekly Watchlist of High Movers - Newser
Is this a good reentry point in Matinas BioPharma Holdings Inc.High Return Idea With Technical Filter - Newser
Will Matinas BioPharma Holdings Inc. bounce back from current supportSafe and Scalable Return Strategy Blueprint - Newser
When is the best time to buy Toppoint Holdings Inc. stock3-Year Equity Summary With Setup Insights - Newser
Key resistance and support levels for Matinas BioPharma Holdings Inc.Asset Allocation Summary With Future Outlook - Newser
Matinas BioPharma Doubles Authorized Common Shares To 500M Following Shareholder Approval - 富途牛牛
What institutional flow reveals about Matinas BioPharma Holdings Inc.Low Drawdown Picks with Weekly Updates - Newser
How to read the order book for Matinas BioPharma Holdings Inc.Market Sentiment Tracker with Smart Alerts - Newser
How to build a custom watchlist for GT Biopharma Inc.Deep Learning Stock Forecast for Investors - Newser
Why Matinas BioPharma Holdings Inc. stock attracts strong analyst attentionTechnical Chart Summary for Momentum Stocks - Newser
How many analysts rate Matinas BioPharma Holdings Inc. as a “Buy”Discover high-growth stocks for your portfolio - Jammu Links News
What makes Matinas BioPharma Holdings Inc. stock price move sharplyFree Real-Time Market Sentiment Tracking Tool - Newser
Matinas BioPharma Holdings Inc. Stock Support and Resistance Levels You Should KnowFree Weekly Hot Picks With Buy Confidence - Newser
Should I hold or sell Matinas BioPharma Holdings Inc. stock in 2025Achieve exceptional returns with expert guidance - Jammu Links News
How strong is Matinas BioPharma Holdings Inc. company’s balance sheetMaximize returns with effective portfolio management - Jammu Links News
What institutional investors are buying Matinas BioPharma Holdings Inc. stockFree Expert Stock Watchlist - Jammu Links News
When is Matinas BioPharma Holdings Inc. stock expected to show significant growthUnlock exclusive trading strategies - Jammu Links News
How does Matinas BioPharma Holdings Inc. compare to its industry peersStrongest growth potential - Jammu Links News
How does Matinas BioPharma Holdings Inc. generate profit in a changing economySuperior investment outcomes - Jammu Links News
Is Matinas BioPharma Holdings Inc. stock overvalued or undervaluedFree Investment Timing Strategies - Jammu Links News
What is the dividend policy of Matinas BioPharma Holdings Inc. stockHigh-velocity capital appreciation - Jammu Links News
What are analysts’ price targets for Matinas BioPharma Holdings Inc. in the next 12 monthsIdentify undervalued stocks poised to rally - jammulinksnews.com
What are Matinas BioPharma Holdings Inc. company’s key revenue driversAchieve remarkable returns with smart investing - jammulinksnews.com
Is Matinas BioPharma Holdings Inc. a good long term investmentMaximize your returns with expert insights - Jammu Links News
What is the risk reward ratio of investing in Matinas BioPharma Holdings Inc. stockSwing Trade Review With Proven Results - Jammu Links News
Can Matinas BioPharma Holdings Inc. recover in the next quarterFree Technical Entry Strategy for Beginners - Newser
What the charts say about Clear Secure Inc. todayPredictive AI Signals for Short-Term Trading - Newser
What institutional flow reveals about Matinas BioPharma Holdings IncRSI and MACD Signal Summary with Trends - Newser
Published on: 2025-07-28 19:10:29 - beatles.ru
Matinas Biopharma Holdings Inc (MTNB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):